The challenges associated with molecular targeted therapies for glioblastoma.
about
Molecular Testing of Brain Tumor.MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Patient-Specific Resection Strategy of Glioblastoma Multiforme: Choice Based on a Preoperative Scoring Scale.Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells.Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles.Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models.New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.What are the prospects for combination therapy for glioblastoma?Haliotis discus discus Sialic Acid-Binding Lectin Reduces the Oncolytic Vaccinia Virus Induced Toxicity in a Glioblastoma Mouse Model.Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.Viability of glioblastoma stem cells is effectively reduced by diisothiocyanate-derived mercapturic acids
P2860
Q33729693-B08B17FD-7F49-485F-9C64-2CA29064FF78Q37694818-7CC11159-B635-4E06-8DFE-CE539E7C7D53Q38676891-D81553D0-AC7B-4E87-8BCA-6EABB1556EEDQ38743138-A06F3630-C04C-4E20-81F4-95B48C42387DQ39189199-6E93C651-4B5F-44A0-AB81-2D4691589D54Q39202839-5C417C33-F071-4E1D-8AED-53896E56478AQ42364091-35FD743E-C10B-44F2-8796-67E11A10802BQ48034442-30E63DB3-9976-468E-9060-A3172A82AD6CQ52366335-8031F69D-5E42-4901-9BA6-4FD4C154BE34Q52590668-568F42BA-06A4-46CE-AAA9-7DC0001C0180Q52655032-F695D52A-2BDB-454F-9BE2-5F8884615DE3Q52691329-6A53BE8A-984A-416E-B29E-7FB4811066E4Q54332453-EFDE03AA-9CBB-4E35-9B75-0F4A6E11DE0AQ54980119-9C112AAD-D2AB-4441-AA78-43E7D269E923Q55363919-7B8D4FA0-C926-4823-A83D-0AAB66DCFE98Q57788675-BF3237E3-C200-4104-B5D4-851CFDF7FEC3
P2860
The challenges associated with molecular targeted therapies for glioblastoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The challenges associated with molecular targeted therapies for glioblastoma.
@en
type
label
The challenges associated with molecular targeted therapies for glioblastoma.
@en
prefLabel
The challenges associated with molecular targeted therapies for glioblastoma.
@en
P2860
P1476
The challenges associated with molecular targeted therapies for glioblastoma.
@en
P2093
Kerrie L McDonald
P2860
P2888
P304
P356
10.1007/S11060-016-2080-6
P50
P577
2016-02-22T00:00:00Z
P6179
1009292520